ProFound Therapeutics
Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia
$35MStrategic
Role not disclosedLoading investors…
Activity from announced rounds
Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
Develops AI-driven drug discovery platform for first- and best-in-class therapeutics
Develops AI-driven crop improvement solutions for climate-resilient crops
Develops AI-powered diagnostic solutions for early detection and care management of diseases